Abstract:Background Alogliptin is the inhibitor of dipeptidyl peptidase-4. It acts to regulate blood sugar by increasing the amount of insulin in the body. Aim A liquid chromatography–mass spectroscopy/mass spectroscopy method was developed for the estimation of alogliptin in spiked human plasma. Liquid–liquid extraction technique was adopted for the extraction of alogliptin from human plasma. Materials and methods The chromatographic separation was performed on a Waters Symmetry shield RP C-18 column with 4.6-mm internal diameter, 5-μm particle size, 100A° pore size analytical column at a flow rate of 1.0 ml/min using a mixture of 0.3% formic acid and acetonitrile in the ratio of 20 : 80% v/v as mobile phase. Positive ion mode was selected to obtain the product ion m/z +339.19 (parent) →245.11 (product) for alogliptin and m/z +303.39 (parent) →232.16 (product) for internal standard. Results The developed method was satisfactorily validated as per United State Food and Drug Administration guidelines for the bioanalytical study because it exhibits excellent intraday and interday accuracy with % nominal 91.06→98.48% and precision percentage coefficient variation less than or equal to 2% in all quality control levels. Alogliptin revealed its linearity with correlation coefficient ( r 2 =0.99) in the concentration range of 40.17–16 096 ng/ml, showed acceptable % extraction recovery (96.18→98.36%), and showed excellent matrix and analyte selectivity (% interference=0), as well as matrix effect (matrix factor 0.931 at lower quantitation limit and 1.14 at high quality control level). The stability study results of bench top, freeze thaw, autosampler, and short-term and long-term showed the accuracy in the range of 92.52–99.16% and percentage coefficient variation in the range of 0.22–1.93. Conclusion The method was successfully optimized and validated as per the United State Food and Drug Administration bioanalytical method development guidelines. The applicability of the developed method undoubtedly can further extend during preclinical and clinical trials.

An HPLC-MS/MS method for quantitation of trelagliptin and application in a comparative pharmacokinetic study

A rapid and sensitive UHPLC-MS/MS assay for the determination of trelagliptin in rat plasma and its application to a pharmacokinetic study.

Development of a validated HPLC method for the quantitative determination of trelagliptin succinate and its related substances in pharmaceutical dosage forms

Investigation of Pharmacokinetic Parameters of Trelagliptin in Egyptian Volunteers Using Sensitive LC-MS/MS: A Comparative Study with a Japanese Population

A High Performance Liquid Chromatography Method for the Quantitative Determination Assay of Sitagliptin in Rat Plasma and Its Application in Pharmacokinetics Study

Simultaneous Determination of Ticagrelor and Its Metabolites in Human Plasma and Urine Using Liquid Chromatography-Tandem Mass Spectrometry

An Hplc-Ms/Ms Method for the Quantitative Determination of Ticagrelor and Its Active Metabolite Ar-C124910xx in Human Plasma and Its Application to A Clinical Study

Suitability of various chromatographic and spectroscopic techniques for analysis and kinetic degradation study of trelagliptin

Quantification of Axitinib After Oral and Intravenous Administration in Rats by UPLC-MS/MS: Application to the Pharmacokinetic Study

Ultra-high pressure liquid chromatography-tandem mass spectrometry method for the determination of omarigliptin in rat plasma and its application to a pharmacokinetic study in rats.

A Validated LC-MS/MS Method for the Simultaneous Determination of Ticagrelor, Its Two Metabolites and Major Constituents of Tea Polyphenols in Rat Plasma and Its Application in a Pharmacokinetic Study.

Liquid chromatography–electro spray ionization–tandem mass spectroscopy method for the quantification of alogliptin in spiked human plasma

The Chiral Bioconversion and Pharmacokinetic Analysis of Trelagliptin in Beagle Dog Plasma by LC-MS/MS

Quantification of Triacontanol and Its PEGylated Prodrug in Rat Plasma by GC–MS/MS: Application to a Pre-Clinical Pharmacokinetic Study

High-throughput bioanalysis of sitagliptin in plasma using direct analysis in real time mass spectrometry and its application in the pharmacokinetic study thereof

Quantitative Analysis of Atractylenolide I in Rat Plasma by LC–MS/MS Method and Its Application to Pharmacokinetic Study

A Rapid and Sensitive Method for the Pharmacokinetic Study of Janumet (sitagliptin and Metformin) Tablets by LC-MS/MS Coupled with Ion-Pair Solid Phase Extraction

Determination of the Enantiomeric Purity of Trelagliptin by Pre-Column Derivatization and Liquid Chromatography on a Chiral Stationary Phase

Simultaneous quantification of metformin and glipizide in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.

SIMULTANEOUS LC-MS/MS QUANTIFICATION METHOD FOR REMOGLIFLOZIN ETABONATE AND METFORMIN IN PLASMA SAMPLES: APPLICATION OF KINETIC STUDY IN RABBITS

Different Spectrophotometric Methods for Simultaneous Determination of Trelagliptin and Its Acid Degradation Product